A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Sequential, Multiple Ascending-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes
收藏官方服务：
资源简介：
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending-doses of TAK-875 in subjects with type 2 diabetes mellitus.
本研究旨在评估多次递增剂量TAK-875在2型糖尿病（type 2 diabetes mellitus）受试者中的安全性、耐受性、药代动力学（pharmacokinetics）与药效动力学（pharmacodynamics）
提供机构：
Vivli创建时间：
2018-10-27
